How RFK Jr.'s war on obesity in the age of Ozempic could shake up the booming weight-loss industry
Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...
STAT13h
The FDA’s risky action on compounding weight loss drugs
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
Poll reveals the amount of Brits who would take weight-loss jabs for free on NHS
A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...
verywellhealth23h
21 Reasons You’re Not Losing Weight—and How to Address Them
Log often, lose more: Electronic dietary self-monitoring for weight loss. Obesity (Silver Spring). 2019;27(3):380-384. doi:10 ...
Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study
For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...
Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Medpage Today on MSN1d
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy
More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.